Pharmaceutical manufacturer
Appears in 1 story
Recalling 22 lots of Argatroban Injection
Par Health pulled 22 lots of its Argatroban Injection off the market after finding bits of cellulose, plastic, and possible stainless steel in the anticoagulant. The injectable treats blood clots in patients with heparin-induced thrombocytopenia, a rare immune reaction to the common blood thinner.
Updated 34 minutes ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
